Vericel Corporation: Advanced cell therapy; marketing MACI (cartilage repair) and Epicel (skin replacement) in TAMs of $2b+. Record Q4 & 2019 MACI and Epicel revs of $39.4m and $117.9m. 2020 revenue guidance for MACI® and Epicel® raised to $141 to $146m. Expanding MACI salesforce to 76 from 49 reps. NexoBrid BLA filing targeted for mid-2020.
Based in...
US - New England
Clinical Stage
Disease Space
Dermatology, Tools
Biotechnology, Medical Device, Medical Technology
Public, USA
Market Cap
500MM - 1B
Therapeutic Modalities
Cell Therapy
64 Sidney Street
Cambridge, MA 02139
United States

Send Message to Request Information

Log in to download presentation, request a 1x1 meeting, view additional roadshows, and more.

Top 10 Holders of Vericel Corporation

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
RTW Investments LP 10.11 4,460,755 67.85 13F 2020-03-31
Deerfield Management Company LP 10.08 4,447,109 67.64 13F 2020-03-31
Brown Capital Management LLC 8.50 3,751,168 57.06 Stakes 2020-05-31
Ivy Investment Management Co. 7.40 3,266,058 49.68 13F 2020-03-31
The Vanguard Group, Inc. 5.38 2,375,549 36.13 Funds 2020-05-31
Vanguard Group, Inc. (Subfiler) 5.29 2,334,585 35.51 13F 2020-03-31
State Street Corp. 4.03 1,779,185 27.06 13F 2020-03-31
BlackRock Fund Advisors 3.52 1,554,596 23.65 13F 2020-03-31
UBS Group AG (13f Subfiler) 3.32 1,464,171 22.27 13F 2020-03-31
BlackRock Institutional Trust Co. NA 3.05 1,344,283 20.45 13F 2020-03-31
Ownership data is sourced through FactSet.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.